| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.23T | 1.09T | 985.33B | 860.48B | 670.81B |
| Gross Profit | 446.81B | 389.75B | 325.89B | 287.67B | 223.63B |
| EBITDA | 240.20B | 200.54B | 158.62B | 120.00B | 107.72B |
| Net Income | 105.40B | 74.92B | 67.23B | 45.92B | 65.50B |
Balance Sheet | |||||
| Total Assets | 2.00T | 1.74T | 1.60T | 1.15T | 984.99B |
| Cash, Cash Equivalents and Short-Term Investments | 107.39B | 136.22B | 97.61B | 75.57B | 42.52B |
| Total Debt | 535.77B | 474.33B | 506.03B | 271.18B | 209.43B |
| Total Liabilities | 958.13B | 831.53B | 851.66B | 527.95B | 452.03B |
| Stockholders Equity | 1.03T | 893.97B | 739.56B | 614.42B | 525.31B |
Cash Flow | |||||
| Free Cash Flow | 24.00B | 17.53B | 101.49B | -15.15B | 32.37B |
| Operating Cash Flow | 135.63B | 94.50B | 159.74B | 39.23B | 68.30B |
| Investing Cash Flow | -241.30B | -1.39B | -344.01B | -46.36B | -4.48B |
| Financing Cash Flow | 68.32B | -63.21B | 205.76B | 35.17B | -55.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥582.81B | 15.81 | 15.27% | 2.93% | 5.23% | -14.98% | |
75 Outperform | ¥470.70B | 7.76 | 8.58% | 2.62% | 4.71% | 12.91% | |
73 Outperform | ¥116.76B | 16.04 | ― | 5.78% | 7.04% | 72.23% | |
70 Outperform | ¥524.23B | 12.60 | 4.89% | 2.59% | -0.40% | 410.92% | |
68 Neutral | ¥4.23T | 14.28 | 6.59% | 3.07% | -0.01% | 19.44% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥995.59B | 9.00 | 9.11% | 1.60% | 12.81% | 42.91% |